COVID-19‎ > ‎

COVID-19 Middle East and North Africa

This page provides analysis, and data summaries of the Genetic Epidemiology of SARS-CoV-2 in Middle East and North Africa. 

This resource is maintained to understand the dynamics of COVID-19 genetic epidemiology in MENA region and to also understand the dynamics of individuals travelling through and from MENA region into India.


Genetic Epidemiology of SARS-CoV-2 in Middle East and North Africa

PhyloVis provides a visual interface using NextStrain for SARS-CoV-2 genomes

We acknowledge the data made available from the following institutions at GISAID
Al Jalila Children's Hospital Al Jalila Genomics Center, UAE
Andersen lab at Scripps Research, 
Biomedical Research Center (BRC), Qatar 
Center of Scientific Excellence for Influenza Viruses, National Research Centre (NRC), Egypt. 
Central Virology Laboratory, Israel Ministry of Health, 
Dasman Diabetes Institute Kuwait
Gen Era Diagnostics Inc. Turkey
General Hospital of Central Theater Command of People's Liberation Army of China , 
Genomic Laboratory (GLAB), Istanbul Technical University, Turkey
Human Genetic Research Center, Infectious Disease Research Department, 
King Abdullah International Medical Research Center (KAIMRC), Saudi Arabia
Israel Institute for Biological Research, Israel
Kawsar Human Genetic Research Center, Kawsar 
Human Genetic Research Company, Ministry of Health Turkey, 
NIC Viral Respiratory Unit - Institut Pasteur of Algeria, 
Pathogen Genomics Lab King Abdullah University of Science and Technology(KAUST), Saudi Arabia
Public Health Laboratory, Saudi CDC , Saudi Arabia